A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
Clinical trial NCT03416816 · TERMINATED
Trial details
- NCT number
- NCT03416816
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2020-06-15
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.